Medartis Holding Future Growth
Future criteria checks 4/6
Medartis Holding is forecast to grow earnings and revenue by 63.5% and 12.7% per annum respectively. EPS is expected to grow by 62.1% per annum. Return on equity is forecast to be 7.5% in 3 years.
Key information
63.5%
Earnings growth rate
62.1%
EPS growth rate
| Medical Equipment earnings growth | 15.7% |
| Revenue growth rate | 12.7% |
| Future return on equity | 7.5% |
| Analyst coverage | Low |
| Last updated | 04 Apr 2024 |
Recent future growth updates
Recent updates
Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation
Apr 11
The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence
Feb 14Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around
Oct 24Is Medartis Holding (VTX:MED) A Risky Investment?
Oct 03Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 06Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)
Jun 21Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital
Jan 31Why Medartis Holding AG (VTX:MED) Could Be Worth Watching
Oct 30These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat
Sep 07When Should You Buy Medartis Holding AG (VTX:MED)?
Jul 29Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital
May 06At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?
Feb 08Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around
Jan 18We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt
Nov 10Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital
Sep 29Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital
Jun 08How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?
Mar 16We're Watching These Trends At Medartis Holding (VTX:MED)
Feb 09
Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain
Jan 04What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?
Nov 19Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 316 | 22 | N/A | 42 | 1 |
| 12/31/2025 | 287 | 16 | 13 | 35 | 2 |
| 12/31/2024 | 247 | 8 | 4 | 27 | 2 |
| 12/31/2023 | 212 | 1 | 1 | 20 | N/A |
| 9/30/2023 | 205 | -3 | -10 | 9 | N/A |
| 6/30/2023 | 198 | -7 | -22 | -2 | N/A |
| 3/31/2023 | 190 | -6 | -22 | -3 | N/A |
| 12/31/2022 | 183 | -6 | -23 | -4 | N/A |
| 9/30/2022 | 178 | -3 | -14 | 2 | N/A |
| 6/30/2022 | 173 | 0 | -5 | 8 | N/A |
| 3/31/2022 | 166 | 3 | 3 | 14 | N/A |
| 12/31/2021 | 160 | 7 | 11 | 21 | N/A |
| 9/30/2021 | 153 | 9 | N/A | N/A | N/A |
| 6/30/2021 | 146 | 12 | 10 | 21 | N/A |
| 3/31/2021 | 137 | 6 | 5 | 17 | N/A |
| 12/31/2020 | 128 | -1 | 0 | 13 | N/A |
| 9/30/2020 | 125 | -3 | N/A | N/A | N/A |
| 6/30/2020 | 123 | -4 | -9 | 8 | N/A |
| 3/31/2020 | 126 | -1 | -10 | 9 | N/A |
| 12/31/2019 | 130 | 2 | -10 | 9 | N/A |
| 9/30/2019 | 127 | 3 | -12 | 7 | N/A |
| 6/30/2019 | 125 | 4 | -13 | 5 | N/A |
| 3/31/2019 | 123 | 4 | -11 | 6 | N/A |
| 12/31/2018 | 121 | 4 | -8 | 6 | N/A |
| 9/30/2018 | 119 | 2 | -4 | 9 | N/A |
| 6/30/2018 | 116 | 0 | -1 | 11 | N/A |
| 3/31/2018 | 111 | 0 | 1 | 11 | N/A |
| 12/31/2017 | 105 | 1 | 2 | 11 | N/A |
| 12/31/2016 | 93 | 3 | N/A | 12 | N/A |
| 12/31/2015 | 82 | 7 | N/A | 12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MED's forecast earnings growth (63.5% per year) is above the savings rate (0.1%).
Earnings vs Market: MED's earnings (63.5% per year) are forecast to grow faster than the Swiss market (7.9% per year).
High Growth Earnings: MED's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MED's revenue (12.7% per year) is forecast to grow faster than the Swiss market (4.3% per year).
High Growth Revenue: MED's revenue (12.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MED's Return on Equity is forecast to be low in 3 years time (7.5%).